BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30

• Lone Star Bio

  Wound Management Technologies, Inc.: CellerateRX(R) Effectively Manages Diabetic Ulcers

  November 11, 2010

   · 

  5 min read
• Biotech Bay

  WaferGen Biosystems Announces IRS Federal Grant Award to Advance Its SmartChip System for Molecular Profiling of Disease States and Therapy Selection

  November 11, 2010

   · 

  5 min read
• Lone Star Bio

  Luminex Corporation to Present at Stephens Fall Investment Conference

  November 11, 2010

   · 

  1 min read
• Genetown

  Generex Biotechnology Corporation: Generex Oncology Awarded Two IRS Therapeutic Discovery Project Grants

  November 11, 2010

   · 

  4 min read
• Drug Development

  Amgen: Study Published in The New England Journal of Medicine Shows Nplate(R) Significantly Reduces Treatment Failure and Splenectomy Rate in Patients With Chronic ITP

  November 11, 2010

   · 

  15 min read
• Drug Development

  Ardea Biosciences, Inc. Announces Data on MEK Inhibitor BAY 86-9766 (RDEA119) to be Presented at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

  November 11, 2010

   · 

  5 min read
• Business

  Waters Corporation Welcomes King’s College London into Waters Centers of Innovation Program

  November 11, 2010

   · 

  4 min read
• Genetown

  Boston Scientific Corporation Announces Sponsorship of World Diabetes Day Campaign 2010

  November 11, 2010

   · 

  3 min read
• Bio NC

  Argos Therapeutics, Inc. to Present Corporate Overview and Next Steps in Clinical Development of Arcelis(TM) Immunotherapy at Lazard Capital Markets 7th Annual Healthcare Conference

  November 11, 2010

   · 

  2 min read
• Drug Development

  NephRx Corporation Initiates Phase I Trial of its Lead Drug Being Developed for Prevention of Delayed Graft Function in Kidney Transplant Patients

  November 11, 2010

   · 

  3 min read